Position in TGTX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$22,108,773
-$3,163,756 QoQ
Shares Held
665,526
-21.5% QoQ
Ownership
0.435%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. TGTX ranks #22 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
896,397 | $205,032,885 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
426,523 | $190,459,579 | |
| 3 | INSM |
INSMED Inc
|
916,464 | $149,860,192 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,330,415 | $98,796,617 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
120,425 | $93,045,171 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
1,753,764 | $84,531,424 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,093,485 | $72,071,595 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
350,488 | $59,239,481 |
All Filings in TGTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,108,773 | 665,526 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $25,272,529 | 847,787 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $28,328,212 | 784,172 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $28,672,296 | 796,674 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $33,161,063 | 841,011 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $24,988,537 | 830,184 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $18,061,477 | 772,188 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $832,874 | 46,817 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $538,038 | 35,374 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $581,607 | 34,052 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $281,229 | 33,640 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $1,293,641 | 52,079 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $962,198 | 63,976 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $468,822 | 39,630 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $212,574 | 35,908 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $155,945 | 36,693 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $379,419 | 39,897 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $743,299 | 39,121 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,839,850 | 55,284 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $2,072,316 | 53,424 | Shares | Defined | 2021-08-10 | |
| 2020-12-31 | $2,712,946 | 52,152 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $971,976 | 36,322 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $721,363 | 37,031 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $247,879 | 25,191 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||